Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-20-001642
Filing Date
2020-01-22
Accepted
2020-01-22 16:11:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 xene-424b5.htm 424B5 1069151
2 GRAPHIC gjsovraxsloc000004.jpg GRAPHIC 2847
3 GRAPHIC gjsovraxsloc000002.jpg GRAPHIC 3875
4 GRAPHIC gjsovraxsloc000003.jpg GRAPHIC 37816
5 GRAPHIC gjsovraxsloc000001.jpg GRAPHIC 2847
  Complete submission text file 0001564590-20-001642.txt   1135986
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233056 | Film No.: 20539051
SIC: 2834 Pharmaceutical Preparations